Since the technology for cell- free DNA/SNP-based testing can be complex, how do you work with the companies and what kind of technical support is required to optimize NIPT in this context?

Since the technology for cell- free DNA/SNP-based testing can be complex, how do you work with the companies and what kind of technical support is required to optimize NIPT in this context?

Since the technology for cell- free DNA/SNP-based testing can be complex, how do you work with the companies and what kind of technical support is required to optimize NIPT in this context?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Mike Ruma, MD, MPH, FACOG

Mike Ruma, MD, MPH, FACOG

Maternal–Fetal Medicine Specialist
Perinatal Associates of New Mexico
Albuquerque, NM